Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emergence of Small Interfering RNA-Based Gene Drugs for Various Diseases. | ACS Omega | 2023 | 37323391 | PubTator, text mining | PubMed |
| N-terminal proteoforms may engage in different protein complexes. | Life Sci Alliance | 2023 | 37316325 | PubTator, text mining | PubMed |
| From words to complete phrases: insight into single-cell isoforms using short and long reads. | Transcription | 2023 | 37314295 | PubTator, text mining | PubMed |
| The First Registered Type 0 Spinal Muscular Atrophy Patient in Latvia: Call for Change in Prenatal Diagnostic Procedures. | Case Rep Med | 2023 | 37303748 | PubTator, text mining | PubMed |
| Splicing activates transcription from weak promoters upstream of alternative exons. | Nat Commun | 2023 | 37301863 | PubTator, text mining | PubMed |
| Group I Intron as a Potential Target for Antifungal Compounds: Development of a Trans-Splicing High-Throughput Screening Strategy. | Molecules | 2023 | 37298936 | PubTator, text mining | PubMed |
| Altered Metabolism in Motor Neuron Diseases: Mechanism and Potential Therapeutic Target. | Cells | 2023 | 37296656 | PubTator, text mining | PubMed |
| Challenges and future perspective of antisense therapy for spinal muscular atrophy: A review. | Eur J Cell Biol | 2023 | 37295266 | PubTator, text mining | PubMed |
| The pros and cons of ubiquitination on the formation of protein condensates. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37294105 | PubTator, text mining | PubMed |
| Utility of Skeletal Muscle CT in Diagnosing Spinal Muscular Atrophy Type 3 in a Patient Who Had Been Undiagnosed for 50 Years. | Cureus | 2023 | 37292524 | PubTator, text mining | PubMed |
| Biomarkers in 5q-associated spinal muscular atrophy-a narrative review. | J Neurol | 2023 | 37289324 | PubTator, text mining | PubMed |
| Assessing Prevalence and Characteristics of Oro-bulbar Involvement in Children and Adults with SMA Type 2 and 3 Using a Multimodal Approach. | Dysphagia | 2023 | 37289231 | PubTator, text mining | PubMed |
| Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME): three new cases and review of the mutational spectrum. | Ital J Pediatr | 2023 | 37280710 | PubTator, text mining | PubMed |
| Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen. | BMC Neurol | 2023 | 37280513 | PubTator, text mining | PubMed |
| A Critical Appraisal of Matching-Adjusted Indirect Comparisons in Spinal Muscular Atrophy. | Adv Ther | 2023 | 37277563 | PubTator, text mining | PubMed |
| Genome sequencing with comprehensive variant calling identifies structural variants and repeat expansions in a large fraction of individuals with ataxia and/or neuromuscular disorders. | Front Neurol | 2023 | 37273706 | PubTator, text mining | PubMed |
| Nsp14 of SARS-CoV-2 inhibits mRNA processing and nuclear export by targeting the nuclear cap-binding complex. | Nucleic Acids Res | 2023 | 37260089 | PubTator, text mining | PubMed |
| Amplifying gene expression with RNA-targeted therapeutics. | Nat Rev Drug Discov | 2023 | 37253858 | PubTator, text mining | PubMed |
| Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen. | J Neuromuscul Dis | 2023 | 37248913 | PubTator, text mining | PubMed |
| Synthetic Routes to Approved Drugs Containing a Spirocycle. | Molecules | 2023 | 37241950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=28